ARA-290
ARA-290 is investigated in research involving tissue-protective signalling, repair pathways and inflammatory modulation.
Research overview
ARA-290, also known as cibinetide in clinical research, is a non-erythropoietic peptide derived from erythropoietin structure. It has been investigated for tissue-protective and innate-repair-receptor signalling without the red-cell-stimulating goal of erythropoietin.
Evidence status
ARA-290/cibinetide has been studied in experimental models and human trials, including neuropathy-related research. Evidence remains indication-specific and investigational.
Areas under investigation
- Innate repair receptor signalling
- Tissue-protective pathways
- Inflammation and neuropathy research
Explore the scientific literature
For primary-source reading, search the indexed biomedical literature and registered clinical studies. These links are provided as research gateways rather than endorsements of any particular finding.